Towa Pharmaceutical Co. Ltd. | Ownership
Companies that own Towa Pharmaceutical Co. Ltd.
LSV Asset Management
1,053,064
6.13%
0
0.09%
09/30/2017
Sompo Japan Nipponkoa Asset Management Co., Ltd.
660,900
3.85%
-207,600
1.67%
05/15/2018
Asset Management One Co., Ltd.
379,700
2.21%
379,700
0.02%
08/31/2018
Fidelity (Canada) Asset Management ULC
225,000
1.31%
0
0.02%
07/31/2018
APG Asset Management NV
216,351
1.26%
-41,363
0.01%
03/31/2018
The Vanguard Group, Inc.
202,121
1.18%
400
0%
07/31/2018
Fidelity Management & Research Co.
193,592
1.12%
496
0%
07/31/2018
Nomura Asset Management Co., Ltd.
166,200
0.97%
-2,299
0.01%
07/31/2018
Dimensional Fund Advisors LP
141,700
0.83%
3,700
0%
04/30/2018
Norges Bank Investment Management
132,679
0.77%
-12,801
0%
12/31/2017
| Address |
2-11 Shinbashi-cho
Kadoma Osaka 571
Japan
|
|
Employees
|
- |
| Website |
http://www.towayakuhin.co.jp |
| Updated |
07/08/2019 |
| Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its products include neurological and anti-allergic drugs, cardiovascular and respiratory drugs, gastrointestinal drugs, antibiotics and chemotherapeutic drugs, vitamins; hormone drugs, and other metabolic drugs. The company was founded in June 1951 and is headquartered in Osaka, Japan. |
